MX380752B - Probiótico para el llanto infantil excesivo. - Google Patents

Probiótico para el llanto infantil excesivo.

Info

Publication number
MX380752B
MX380752B MX2016001635A MX2016001635A MX380752B MX 380752 B MX380752 B MX 380752B MX 2016001635 A MX2016001635 A MX 2016001635A MX 2016001635 A MX2016001635 A MX 2016001635A MX 380752 B MX380752 B MX 380752B
Authority
MX
Mexico
Prior art keywords
sup
excessive
probiotic
bacterial composition
infant
Prior art date
Application number
MX2016001635A
Other languages
English (en)
Other versions
MX2016001635A (es
Inventor
Mallén Elísabet Lázaro
Castellana Jordi Cuñe
Mazo Jordi Espadaler
Original Assignee
Ab Biotics Sa
Venpharma Laboratorios S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Biotics Sa, Venpharma Laboratorios S A filed Critical Ab Biotics Sa
Publication of MX2016001635A publication Critical patent/MX2016001635A/es
Publication of MX380752B publication Critical patent/MX380752B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/206—Bacterial extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/41—Pediococcus
    • A23V2400/427—Pentosaceus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pediatric Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención se refiere a una composición bacteriana que comprende de 104 a 1012 ufc/g de células de Pediococcus pentosaceus que tienen la capacidad de inducir la producción de interleucina-10 para reducir la inflamación en el tracto intestinal entre otras características. Por lo tanto, la composición bacteriana es útil en la mejora de llanto excesivo en los bebés. En particular, las células de Pediococcus pentosaceus son de la cepa depositada como CECT 8330. La composición bacteriana puede estar en la forma de un suplemento dietético, un medicamento, una fórmula para bebés y un producto alimenticio. En particular, la composición está en la forma de un suplemento dietético para lactantes, en forma de suspensión oleosa.
MX2016001635A 2013-08-09 2014-08-07 Probiótico para el llanto infantil excesivo. MX380752B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13382324 2013-08-09
PCT/EP2014/066970 WO2015018883A2 (en) 2013-08-09 2014-08-07 Probiotic for infantile excessive crying

Publications (2)

Publication Number Publication Date
MX2016001635A MX2016001635A (es) 2016-10-07
MX380752B true MX380752B (es) 2025-03-12

Family

ID=49029044

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016001635A MX380752B (es) 2013-08-09 2014-08-07 Probiótico para el llanto infantil excesivo.
MX2021000259A MX2021000259A (es) 2013-08-09 2016-02-05 Probiotico para el llanto infantil excesivo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021000259A MX2021000259A (es) 2013-08-09 2016-02-05 Probiotico para el llanto infantil excesivo.

Country Status (17)

Country Link
US (2) US10265351B2 (es)
EP (1) EP3030247B1 (es)
JP (1) JP6643988B2 (es)
KR (1) KR102084825B1 (es)
CN (2) CN111676171B (es)
AU (1) AU2014304535B2 (es)
BR (1) BR112016002650A2 (es)
CA (1) CA2920461C (es)
DK (1) DK3030247T3 (es)
EA (1) EA034531B9 (es)
ES (1) ES2683190T3 (es)
HU (1) HUE039336T2 (es)
MX (2) MX380752B (es)
PH (1) PH12016500271A1 (es)
PL (1) PL3030247T3 (es)
TW (1) TW201536302A (es)
WO (1) WO2015018883A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
AU2018263770A1 (en) * 2017-05-05 2019-10-03 Societe Des Produits Nestle S.A. Treatment of infant colic
JP6836756B2 (ja) * 2017-09-21 2021-03-03 光博 岡野 口腔細菌叢中の構成叢比を予測する方法
EP3708649A4 (en) * 2017-11-10 2021-08-18 Amtixbio Co., Ltd. NEW STRAIN AB 160011 DEPEDIOCOCCUS PENTOSACEUS
KR102434641B1 (ko) * 2018-11-23 2022-08-23 한국식품연구원 페디오코쿠스 펜토사세우스를 이용한 호흡기 기능 개선용 식품 조성물
WO2021231504A1 (en) * 2020-05-12 2021-11-18 Rpi Consulting Llc Systems and methods for isolating and testing blood for biomarkers and genetic material
WO2023285573A1 (en) 2021-07-13 2023-01-19 Ab-Biotics, S.A. Probiotic composition for the treatment of increased intestinal permeability
JP2025509154A (ja) 2022-03-08 2025-04-11 エクアシールド メディカル リミテッド ロボット医薬品調製システムにおける流体移送ステーション

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
SE0400355D0 (sv) * 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
ATE544457T1 (de) * 2007-02-28 2012-02-15 Mead Johnson Nutrition Co Verfahren zur behandlung bzw. prävention systemischer entzündungen
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
JP5531321B2 (ja) * 2009-03-31 2014-06-25 キッコーマン株式会社 Ｉｌ−１０産生促進作用を有する免疫賦活組成物
TWI415942B (zh) * 2009-10-15 2013-11-21 Food Industry Res & Dev Inst 生產胞外多醣的方法以及一新穎的乳酸小球菌分離株
MX2012006640A (es) * 2009-12-08 2012-06-25 Nestec Sa Formula infantil con probioticos y componentes de la membrana del globulo graso de la leche.
SG191393A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes

Also Published As

Publication number Publication date
PL3030247T3 (pl) 2019-02-28
JP2016526918A (ja) 2016-09-08
EP3030247A2 (en) 2016-06-15
WO2015018883A2 (en) 2015-02-12
DK3030247T3 (en) 2018-08-13
BR112016002650A2 (pt) 2017-09-12
US20160184371A1 (en) 2016-06-30
EA034531B9 (ru) 2020-03-19
ES2683190T3 (es) 2018-09-25
PH12016500271A1 (en) 2016-05-16
US20180008652A1 (en) 2018-01-11
KR20160046826A (ko) 2016-04-29
CN111676171B (zh) 2023-06-06
HUE039336T2 (hu) 2018-12-28
US10265351B2 (en) 2019-04-23
MX2021000259A (es) 2021-03-25
MX2016001635A (es) 2016-10-07
AU2014304535B2 (en) 2017-06-15
JP6643988B2 (ja) 2020-02-12
TW201536302A (zh) 2015-10-01
AU2014304535A1 (en) 2016-03-10
EP3030247B1 (en) 2018-05-16
EA034531B1 (ru) 2020-02-18
CA3176938A1 (en) 2015-02-12
EA201690196A1 (ru) 2016-12-30
WO2015018883A3 (en) 2015-04-02
KR102084825B1 (ko) 2020-03-04
CN105555283A (zh) 2016-05-04
CN105555283B (zh) 2020-08-11
CA2920461C (en) 2023-01-03
CN111676171A (zh) 2020-09-18
CA2920461A1 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
MX380752B (es) Probiótico para el llanto infantil excesivo.
EA202090948A1 (ru) Иммуномодуляция
MX379226B (es) Composiciones y métodos para tratar trastornos metabólicos.
BR112012024102A2 (pt) Composição nutricional, uso da composição nutricional, uso não médico da composição nutricional, e uso não médico de uma fórmula infantil para alimentar uma criança
BR112013028705A2 (pt) cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes
EE05750B1 (et) Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
FI3389407T3 (fi) Ravintokoostumus ja äidinmaidonkorvike de novo myelinaation edistämiseksi
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
SI2809168T1 (sl) Večslojne mikroenkapsulirane probiotične bakterije kot tudi živila in farmacevtski sestavki, ki vsebujejo omenjene bakterije
RU2013114313A (ru) Противокариесные композиции и пробиотики/пребиотики
IN2013DN03771A (es)
EA201592003A1 (ru) Микропищевые добавки для иммунитета
PH12012501704B1 (en) Nutritional compositions
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
PL405575A1 (pl) Prozdrowotny produkt spożywczy
JP2015533484A5 (es)
MY177993A (en) Agent for ameliorating allergy
RU2013154564A (ru) Способы и композиции для стимуляции роста безжировой массы тела
PL414701A1 (pl) Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
GR20110100600A (el) Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
IN2014MN01459A (es)